|
|
 |
POVIDONE K29/32 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYOXYL 20 CETOSTEARYL ETHER Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYVINYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYOXYL 35 CASTOR OIL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POLYVINYL ACETATE PHTHALATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
POVIDONES Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|